UnitedHealth Group Incorporated
NYSE:UNHMedical - Healthcare Plans
+$3.69 today
- Market cap
- $313.53B
- Beta
- 0.65
- P/E (TTM)
- 30.5
- EPS (TTM)
- $13.24
- Dividend yield
- 2.22%
Volume 17.34M
Average 8.23M
UNH Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
UnitedHealth Group IncorporatedNYSE: UNH
Selling, General & Admin · Q3 FY2026 · quarter ended Sep 2026
Selling, general & admin remains negative
Q3 FY2026 selling, general & admin was $0, compared with $0 a year earlier. Trailing-twelve-month selling, general & admin was $15.39B.
Context
- Selling, general & admin amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Selling, general & admin increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly selling, general & admin holds near $0 or moves back toward the trailing-twelve-month quarterly average of $3.85B.
Sources:Income StatementText generated from reported figures; not investment advice.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Selling, General & Admin vs competitors
How UNH compares with its peers on the latest reported figures
- UNH's LTM Sep 2026 selling, general & admin of $15.39B is the highest of the 9 companies compared; the peer median is $5.79B.
- Selling, general & admin amounts to 3.4% of revenue for UNH, versus a peer median of 5.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $15.39B | — | — | 3.4% | |
| LTM Jun 2026 | $13.37B | +5.5% | +4.6% | 6.9% | |
| LTM Sep 2026 | $12.08B | — | — | 6.0% | |
| LTM Sep 2026 | $10.6B | -26.1% | +2.4% | 3.7% | |
| LTM Sep 2026 | $8.58B | — | — | 5.6% | |
| LTM Sep 2026 | $3.01B | +4.5% | +9.2% | 6.9% | |
| LTM Jun 2026 | $1.22B | +164.9% | +13.0% | 7.9% | |
| LTM Mar 2026 | $121.14M | -56.9% | — | 2.8% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding UNH) | $5.79B | +4.5% | +6.9% | 5.8% | |
Competitors are the stored peer set for UNH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 287.6B | 324.16B | 371.62B | 400.28B | 447.57B |
| Cost of Revenue | 217.95B | 244.55B | 280.66B | 310.88B | 364.65B |
| Gross Profit | 69.65B | 79.62B | 90.96B | 89.4B | 82.92B |
| Gross Margin | 24.2% | 24.6% | 24.5% | 22.3% | 18.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 45.68B | 51.18B | 58.6B | 57.11B | 63.95B |
| Depreciation & Amortization | 3.1B | 3.4B | 3.97B | 4.1B | 4.36B |
| EBITDA | 27.07B | 31.84B | 36.33B | 28.08B | 23.06B |
| EBITDA Margin | 9.4% | 9.8% | 9.8% | 7.0% | 5.2% |
| Operating Income | 23.97B | 28.44B | 32.36B | 32.29B | 18.96B |
| Operating Margin | 8.3% | 8.8% | 8.7% | 8.1% | 4.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.66B | 2.09B | 3.25B | 3.91B | 4B |
| Other Income / Expenses | (1.66B) | (2.09B) | (3.25B) | (12.22B) | (4.27B) |
| Income Before Tax | 22.31B | 26.34B | 29.11B | 20.07B | 14.7B |
| Pre-Tax Margin | 7.8% | 8.1% | 7.8% | 5.0% | 3.3% |
| Income Tax Expense | 4.58B | 5.7B | 5.97B | 4.83B | 1.89B |
| Net Income | 17.29B | 20.12B | 22.38B | 14.41B | 12.06B |
| Net Margin | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| EPS (Basic) | 18.33 | 21.54 | 24.12 | 15.64 | 13.23 |
| EPS (Diluted) | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 |
| Weighted Avg Shares | 943M | 934M | 928M | 929M | 910M |
| Weighted Avg Shares (Diluted) | 956M | 950M | 938M | 929M | 910M |
UnitedHealth Group Incorporated
NYSE:UNH
Intrinsic Alpha fair value
Locked
Current Price
$349.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.